Cannabis, psychedelic and plant-based food stocks were extremely oversold in 2022 but we're watching to see if any of them could possibly bounce back with major returns - dare I say "multi-bagger" returns - in 2023. As such, I'm watching 12 microcap stocks with market capitalizations between $100M and $399M (average of $189M), which I'm calling the munKNEE "Multi-bagger" Portfolio.

Here's an update on how the various categories in the Portfolio, and their constituents, have performed year-to-date and last week.

1. American Cannabis MSO constituents:
   • Acreage (ACRDF/ACRHF): +41.7% YTD, -11.9% last week;
   • Ascend (AAWH): +4.6% YTD, -1.4% last week;
   • Ayr (AYRWF): +11.6% YTD, +6.3% last week;
   • Columbia Care (CCHWF): -6.7% YTD, -4.1 last week;
   • Jushi (JUSHF): +1.4% YTD, +27.1% last week; and
   • Planet 13 (PLNHF): +31.9% YTD, +1.1% last week.
     • +14.9% YTD; Last week: -0.4%
2. Canadian Cannabis LP constituents:
   • Aurora (ACB): +2.2% YTD, -14.2% last week; and
   • Organigram (OGI): +7.7% YTD, -7.7% last week.
     • +4.8% YTD; Last week: -11.2%
3. Psychedelic Drug Stock constituents:
   • Cybin (CYBN): + 44.8% YTD, -4.5% last week;
   • Mind Medicine (MNMD): +73.9% YTD, +9.5% last week; and
   • Seelos Therapeutics (SEEL): +12.3% YTD, -13.1% last week.
     • +51.9% YTD; Last week: No Change
4. Plant-Based Food Stock constituent:
   • Tattooed Chef (TTCF): No Change YTD, -24.8% last week.
     •  No Change YTD; Last week: -24.8%

Grand Total: +21.6% YTD; Last week: -4.4% 

The munKNEE "Multi-bagger" Portfolio continues to outperform our munKNEE "Rags-to-Riches" Portfolio, which is only up 6.2% YTD and was DOWN 7.8% last week.

Also, for the purposes of comparison with other market portfolios, we're also calling the 8 stocks in groups 1 and 2 our "Just Cannabis Multi-Bagger
 portfolio". It's up 12.7% YTD.

More By This Author:

Canadian Cannabis LPs: CGC's Plunge Drags Category Down
Canopy Q3: Revenue -14%, Net Loss +15%; To Cut Jobs By ~60%
Aurora Q2 Financials: Net Revenue +25%, Net Profit -30%, Adj. EBITDA Turned Positive